Tag: TCT 2024
Attention turns to multi-organ denervation as new evidence supports “durability” of...
New research will investigate the safety and efficacy of multi-organ, hepatic artery and renal artery denervation using the Symplicty Spyral (Medtronic) catheter in uncontrolled...
TCT 2024: Two-year SPYRAL HTN-ON MED data show “consistent” effect of...
Medtronic has announced new, long-term data from the SPYRAL HTN-ON MED clinical trial that showed subjects who underwent radiofrequency renal denervation with the Symplicity...